disponibile in formato PDF - Stampa alternativa
disponibile in formato PDF - Stampa alternativa
disponibile in formato PDF - Stampa alternativa
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Simpaticomimetici: le amfetam<strong>in</strong>e e l’adrenal<strong>in</strong>a hanno un effetto<br />
additivo sulla tachicardia e sull’aumento della pressione arteriosa.<br />
Teofill<strong>in</strong>a: il metabolismo della teofill<strong>in</strong>a è accelerato dal THC, per cui<br />
possono essere necessarie dosi più elevate di teofill<strong>in</strong>a.<br />
(Tratto da: Grotenhermen, F., “Practical H<strong>in</strong>ts”, <strong>in</strong>: Grotenhermen, F., Russo,<br />
E., (a cura di), Cannabis and Cannab<strong>in</strong>oids. Pharmacology, Toxicology, and<br />
Therapeutic Potential, B<strong>in</strong>ghamton, Haworth Press, 2002, pp. 354-355.)<br />
BIBLIOGRAFIA GENERALE<br />
■ Abrams, D., et al., “Short-term Safety of Cannab<strong>in</strong>oids <strong>in</strong> HIV Patients”, <strong>in</strong>:<br />
Poster 744, 8th CROI, 2001.<br />
■ Achiron, A., et al., “Dexanab<strong>in</strong>ol (HU-211) Effect on Experimental<br />
Autoimmune Encephalomyelitis: Implications for the Treatment of Acute<br />
Relapses of Multiple Sclerosis”, <strong>in</strong>: Journal of Neuroimmunology, vol. 102,<br />
2000, pp. 26-31.<br />
■ Alward, W.L., “Medical Management of Glaucoma”, <strong>in</strong>: N Engl J Med, vol.<br />
339, 1998,pp. 1298-1307.<br />
■ Baker, D. et al., “Cannab<strong>in</strong>oids Control Spasticity and Tremor <strong>in</strong> a Multiple<br />
Sclerosis Model”, <strong>in</strong>: Nature, vol. 404, 2000, pp. 84-87.<br />
■ Beal, J.E., et al., “Dronab<strong>in</strong>ol as a Treatment for Anorexia Associated with<br />
Weight Loss <strong>in</strong> Patients with AIDS”, <strong>in</strong>: Journal of Pa<strong>in</strong> and Symptom<br />
Management, vol. 10, 1995, pp. 89-97.<br />
■ Benigni, R., Capra, C., Cattor<strong>in</strong>i, P.E., Erbe medic<strong>in</strong>ali: chimica, farmacologia<br />
e terapia, Milano, Inverni Della Beffa 1962-64, p. 214.<br />
■ Bianchi, G., Ospedale La Colletta, Arenzano, Genova, Comunicazione<br />
privata, 2002.<br />
■ Bianchi, M., Usi <strong>in</strong>novativi di farmaci antichi. L’attuale rivalutazione della<br />
cannabis e dei cannab<strong>in</strong>oidi, Convegno Università La Sapienza, Roma, 6-10-2001.<br />
■ Bid<strong>in</strong>ger, B., Burnste<strong>in</strong>, S.H., Furse, R.K., Rossetti, R.G., Zurier, R.B.,<br />
Suppression of Human Monocyte Interleuk<strong>in</strong>-1 Production by Ajulemic Acid<br />
(CT3), a Non-psychoactive Cannab<strong>in</strong>oid, IRCS Annual Symposium on the<br />
Cannab<strong>in</strong>oids, July 2002.<br />
■ Bifulco, M., Laezza, C., Portella, G., Vitale, M., Orlando, P., De Petrocellis,<br />
L., Di Marzo, V., “Control by the Endogenous Cannab<strong>in</strong>oid System of Ras<br />
Oncogene-dependent Tumor Growth”, <strong>in</strong>: FASEB J., vol. 15, 2001, pp. 2745-<br />
2747.<br />
127